| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |